Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Life Sciences Industry Analysis

UpdatedAug 14, 2025
DataAggregated Company Financials
Companies14
  • 7D-2.2%
  • 3M6.1%
  • 1Y-2.2%
  • YTD-11.3%

Over the last 7 days, the Life Sciences industry has dropped 2.2%, driven by a pullback from Carna Biosciences of 26%. In contrast, Shin Nippon Biomedical Laboratories has gained 6.5%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 9.8% annually.

Industry Valuation and Performance

Has the Japanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 14 Aug 2025JP¥142.2bJP¥66.7bJP¥1.2b17.5x119.3x2.1x
Sat, 12 Jul 2025JP¥141.7bJP¥66.0bJP¥1.1b16x125.5x2.1x
Mon, 09 Jun 2025JP¥135.2bJP¥66.0bJP¥1.1b16.8x119.3x2x
Wed, 07 May 2025JP¥143.7bJP¥64.2bJP¥1.5b14.8x93.5x2.2x
Fri, 04 Apr 2025JP¥145.3bJP¥64.8bJP¥928.0m14x156.5x2.2x
Sun, 02 Mar 2025JP¥161.6bJP¥65.1bJP¥1.1b15.5x144.9x2.5x
Tue, 28 Jan 2025JP¥164.9bJP¥62.0bJP¥440.7m18x374.2x2.7x
Thu, 26 Dec 2024JP¥161.3bJP¥62.0bJP¥440.7m17.9x365.9x2.6x
Sat, 23 Nov 2024JP¥161.9bJP¥62.6bJP¥1.2b20.2x130.6x2.6x
Mon, 21 Oct 2024JP¥155.0bJP¥61.5bJP¥1.8b22.6x84.2x2.5x
Wed, 18 Sep 2024JP¥150.2bJP¥53.8bJP¥1.5b16.2x100.2x2.8x
Fri, 16 Aug 2024JP¥150.8bJP¥61.9bJP¥2.2b18.5x69.2x2.4x
Sun, 14 Jul 2024JP¥164.4bJP¥61.8bJP¥3.2b26.1x50.8x2.7x
Tue, 11 Jun 2024JP¥162.9bJP¥61.8bJP¥3.3b25.6x49.8x2.6x
Thu, 09 May 2024JP¥175.9bJP¥62.3bJP¥3.3b14.2x53.5x2.8x
Sat, 06 Apr 2024JP¥181.2bJP¥62.3bJP¥3.3b14.5x55.1x2.9x
Mon, 04 Mar 2024JP¥240.5bJP¥155.3bJP¥8.7b14.1x27.7x1.5x
Wed, 31 Jan 2024JP¥225.8bJP¥167.1bJP¥8.5b15.3x26.6x1.4x
Fri, 29 Dec 2023JP¥226.1bJP¥167.1bJP¥8.5b15.2x26.6x1.4x
Sun, 26 Nov 2023JP¥238.2bJP¥167.4bJP¥8.7b15.1x27.4x1.4x
Tue, 24 Oct 2023JP¥224.5bJP¥179.3bJP¥12.8b14.1x17.6x1.3x
Thu, 21 Sep 2023JP¥251.8bJP¥179.3bJP¥12.8b15.4x19.7x1.4x
Sat, 19 Aug 2023JP¥257.6bJP¥179.2bJP¥12.7b15.5x20.2x1.4x
Mon, 17 Jul 2023JP¥270.1bJP¥178.5bJP¥16.2b16.6x16.6x1.5x
Wed, 14 Jun 2023JP¥289.0bJP¥178.3bJP¥16.2b17.3x17.8x1.6x
Fri, 12 May 2023JP¥286.9bJP¥178.9bJP¥16.3b16.1x17.6x1.6x
Sun, 09 Apr 2023JP¥300.0bJP¥171.9bJP¥13.3b17x22.6x1.7x
Tue, 07 Mar 2023JP¥335.4bJP¥171.6bJP¥13.2b18x25.4x2x
Thu, 02 Feb 2023JP¥290.0bJP¥172.1bJP¥14.2b15.7x20.5x1.7x
Sat, 31 Dec 2022JP¥297.8bJP¥166.1bJP¥16.2b15.3x18.4x1.8x
Mon, 28 Nov 2022JP¥332.5bJP¥165.5bJP¥16.0b15.6x20.8x2x
Wed, 26 Oct 2022JP¥319.0bJP¥160.1bJP¥12.4b16x25.8x2x
Fri, 23 Sep 2022JP¥314.6bJP¥160.1bJP¥12.4b18.4x25.4x2x
Sun, 21 Aug 2022JP¥311.1bJP¥159.7bJP¥12.3b18.8x25.4x1.9x
Price to Earnings Ratio

25.4x


Total Market Cap: JP¥311.1bTotal Earnings: JP¥12.3bTotal Revenue: JP¥159.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Life Sciences Industry Price to Earnings3Y Average 70.9x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 119x which is higher than its 3-year average PE of 70.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 54% per year over the last three years,
  • Revenues have also declined 25% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market3.85%
Healthcare-0.69%
Life Sciences-2.18%
Clinical Research and Equipment-2.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2395 Shin Nippon Biomedical LaboratoriesJP¥1.55k6.5%
+JP¥3.9b		43.3%PE12.7x
2183 LinicalJP¥363.007.1%
+JP¥542.1m		-2.4%PS0.8x
4583 Chiome BioscienceJP¥141.000.7%
+JP¥107.9m		28.2%PS12.5x
4892 Cyfuse Biomedical K.KJP¥661.000.9%
+JP¥49.8m		4.1%PS80.7x
4241 atectJP¥429.002.4%
+JP¥44.2m		-22.6%PE32.7x

Latest News

4583
JP¥141.00
Chiome Bioscience
7D
0.7%
1Y
28.2%
130A
JP¥736.00
Veritas In Silico
7D
-8.5%
1Y
-18.4%
6090
JP¥737.00
Human Metabolome Technologies
7D
-5.4%
1Y
28.2%
4241
JP¥429.00
atect
7D
2.4%
1Y
-22.6%
4570
JP¥490.00
Immuno-Biological Laboratories
7D
-3.4%
1Y
9.1%
7079
JP¥2,670.00
WDB coco
7D
-12.9%
1Y
-30.5%
2395
JP¥1,549.00
Shin Nippon Biomedical Laboratories
7D
6.5%
1Y
43.3%

Shin Nippon Biomedical Laboratories, Ltd. Recorded A 6.7% Miss On Revenue: Analysts Are Revisiting Their Models

Aug 08
Shin Nippon Biomedical Laboratories, Ltd. Recorded A 6.7% Miss On Revenue: Analysts Are Revisiting Their Models
4572
JP¥227.00
Carna Biosciences
7D
-25.8%
1Y
-41.3%
6190
JP¥445.00
PhoenixBio
7D
-7.7%
1Y
-11.7%

Is PhoenixBio (TSE:6190) A Risky Investment?

Aug 05
Is PhoenixBio (TSE:6190) A Risky Investment?
4880
JP¥680.00
CellSource
7D
-2.6%
1Y
-51.0%
2370
JP¥38.00
MEDINET
7D
-2.6%
1Y
-15.6%
2183
JP¥363.00
Linical
7D
7.1%
1Y
-2.4%
4892
JP¥661.00
Cyfuse Biomedical K.K
7D
0.9%
1Y
4.1%